$245 Million is the total value of Callan Capital, LLC's 68 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 17.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PRF | Buy | Powershs Exch Trad Fd Tr | $51,044,000 | +4.7% | 563,893 | +2.0% | 20.84% | +2.0% |
VEU | Buy | Vanguard Intl Eqty Index | $43,820,000 | +4.2% | 1,022,642 | +4.9% | 17.89% | +1.4% |
NK | Nantkwest Inc | $23,406,000 | -24.3% | 3,763,086 | 0.0% | 9.56% | -26.3% | |
GSLC | Buy | Goldman Sachs Actvbeta | $13,770,000 | +14.9% | 324,375 | +13.6% | 5.62% | +11.9% |
XLK | Buy | Sector Spdr Tech Select | $11,741,000 | -1.3% | 270,717 | +1.0% | 4.79% | -3.9% |
VCSH | Buy | Vanguard Corp Bond Etf | $10,342,000 | +46.6% | 127,926 | +45.1% | 4.22% | +42.7% |
XLV | Buy | Sector Spdr Health Fund | $8,098,000 | +8.0% | 112,934 | +2.1% | 3.31% | +5.2% |
XLF | Buy | Sector Spdr Fincl Select | $6,870,000 | +2.9% | 300,598 | +1.3% | 2.80% | +0.2% |
XLY | Buy | Sector Spdr Consumer Fd | $6,806,000 | +2.1% | 87,183 | +3.5% | 2.78% | -0.5% |
BND | Buy | Vanguard Bond Index Fund | $6,414,000 | +50.8% | 76,085 | +48.2% | 2.62% | +46.9% |
VO | Buy | Vanguard Mid Cap | $5,558,000 | +2.0% | 44,961 | +0.0% | 2.27% | -0.7% |
XLP | Buy | Sector Spdr Tr Con Stpls | $5,555,000 | +6.5% | 100,728 | +2.5% | 2.27% | +3.7% |
XLI | Buy | Sector Spdr Indl Select | $5,444,000 | +2.6% | 97,195 | +1.6% | 2.22% | -0.1% |
PRFZ | Sell | Powershs ETF Small - Mid | $5,370,000 | +1.9% | 55,193 | -1.1% | 2.19% | -0.8% |
SCHZ | Sell | Sch US Agg Bnd Etf | $4,101,000 | +1.6% | 76,341 | -0.1% | 1.67% | -1.1% |
XLE | Buy | Sector Spdr Engy Select | $3,772,000 | +16.2% | 55,272 | +5.4% | 1.54% | +13.2% |
BDX | Becton Dickinson & Co | $2,161,000 | +11.7% | 12,740 | 0.0% | 0.88% | +8.8% | |
SCHB | Sell | Schw US Brd Mkt Etf | $1,819,000 | -43.7% | 36,171 | -44.8% | 0.74% | -45.2% |
XLU | Buy | Sector Spdr Util Select | $1,735,000 | +9.3% | 33,065 | +3.3% | 0.71% | +6.3% |
IEV | Ishares S&P Euro 350 Idx | $1,716,000 | -3.4% | 45,418 | 0.0% | 0.70% | -5.9% | |
XLB | Sell | Sector Spdr Materials Fd | $1,663,000 | +2.7% | 35,890 | -0.7% | 0.68% | 0.0% |
IYF | Sell | Ishares Tr Dj US Finl | $1,594,000 | -4.1% | 18,551 | -5.6% | 0.65% | -6.6% |
FNDB | New | Sch Fnd US Mkt Etf | $1,343,000 | – | 44,734 | +100.0% | 0.55% | – |
VGK | Sell | Vanguard European | $1,341,000 | -4.4% | 28,745 | -0.6% | 0.55% | -7.0% |
SPY | Buy | S P D R TRUST Unit SR | $1,288,000 | +26.8% | 6,151 | +24.5% | 0.53% | +23.5% |
ARE | Sell | Alexandria Real Est Eqty | $1,150,000 | +9.7% | 11,108 | -3.7% | 0.47% | +6.8% |
SCHF | Sell | Schw Intl Eq Etf | $1,134,000 | -39.3% | 41,831 | -39.3% | 0.46% | -40.9% |
AMLP | Buy | Alps TRUST Etf | $1,100,000 | +18.8% | 86,484 | +2.0% | 0.45% | +15.7% |
RMD | Sell | Resmed Inc | $1,023,000 | -14.2% | 16,183 | -21.6% | 0.42% | -16.4% |
BIIB | Sell | Biogen Idec Inc | $881,000 | -19.3% | 3,644 | -13.2% | 0.36% | -21.4% |
EWJ | Buy | Ishares Msci Jpn Idx Fd | $806,000 | +19.4% | 70,045 | +18.4% | 0.33% | +16.3% |
FNDF | New | Sch Fnd Intl Lg Etf | $781,000 | – | 32,890 | +100.0% | 0.32% | – |
NBIX | Sell | Neurocrine Biosciences | $682,000 | -21.6% | 15,000 | -31.8% | 0.28% | -23.8% |
SCHE | Sell | Schwab Emerging Markets | $640,000 | +1.9% | 30,062 | -0.6% | 0.26% | -0.8% |
MON | Monsanto Co New Del | $631,000 | +17.9% | 6,098 | 0.0% | 0.26% | +15.2% | |
VDE | Sell | Vanguard Energy | $600,000 | -6.5% | 6,308 | -15.6% | 0.24% | -8.9% |
MBFI | Sell | M B Financial Inc New | $504,000 | -1.2% | 13,905 | -11.5% | 0.21% | -3.7% |
RLY | Spdr Ssga Exch Traded Fd | $490,000 | +4.9% | 20,130 | 0.0% | 0.20% | +2.0% | |
DSI | Sell | Ishares TRUST Msci | $461,000 | -4.2% | 5,954 | -5.2% | 0.19% | -6.9% |
MLPX | Global X MLP & Energy Infrastr | $449,000 | +20.4% | 32,503 | 0.0% | 0.18% | +17.3% | |
AAXJ | Sell | Ishares Msci All Country | $447,000 | -8.4% | 8,172 | -8.5% | 0.18% | -11.2% |
KND | Buy | KINDRED HEALTHCARE INC. | $446,000 | +9.0% | 39,494 | +19.4% | 0.18% | +6.4% |
CMBS | Ishares Etf | $421,000 | +2.4% | 7,910 | 0.0% | 0.17% | 0.0% | |
AGIO | Buy | Agios Pharmaceuticals | $419,000 | +47.5% | 10,000 | +42.9% | 0.17% | +43.7% |
EBND | Spdr Barclays Etf | $376,000 | +3.3% | 13,503 | 0.0% | 0.15% | +0.7% | |
DXJ | Sell | Wisdomtree Japan Tot Div | $372,000 | -19.5% | 9,592 | -9.3% | 0.15% | -21.6% |
EWC | Buy | Ishares Msci Cda Idx Fd | $368,000 | +31.4% | 15,022 | +27.3% | 0.15% | +28.2% |
BPI | Buy | Bridgepoint Education | $355,000 | -20.0% | 49,036 | +11.3% | 0.14% | -22.0% |
MINT | New | Pimco Exch Traded Fund | $314,000 | – | 3,103 | +100.0% | 0.13% | – |
CELG | Celgene Corp | $306,000 | -1.3% | 3,100 | 0.0% | 0.12% | -3.8% | |
TSLA | Sell | Tesla Motors Inc | $278,000 | -22.3% | 1,310 | -16.0% | 0.11% | -24.7% |
CTLT | New | Catalent Inc | $269,000 | – | 11,700 | +100.0% | 0.11% | – |
DLN | Sell | Wisdomtree Largecap Div | $260,000 | -5.8% | 3,436 | -8.6% | 0.11% | -8.6% |
EPP | Buy | Ishares Msci Pac Ex Japn | $248,000 | +18.7% | 6,330 | +18.7% | 0.10% | +14.8% |
ILMN | Buy | Illumina Inc | $242,000 | -11.4% | 1,724 | +2.4% | 0.10% | -13.2% |
VWO | Sell | Vanguard Emerging Market | $241,000 | -41.4% | 6,832 | -42.6% | 0.10% | -43.0% |
IVV | Ishares TRUST S&P | $215,000 | +1.9% | 1,020 | 0.0% | 0.09% | 0.0% | |
PPBI | New | Pacific Premier Bancorp | $213,000 | – | 8,862 | +100.0% | 0.09% | – |
DEPO | Depomed Inc | $210,000 | +40.9% | 10,700 | 0.0% | 0.09% | +38.7% | |
WMAR | New | West Marine Inc | $169,000 | – | 20,200 | +100.0% | 0.07% | – |
SQNM | Sequenom Inc New | $162,000 | -34.9% | 176,777 | 0.0% | 0.07% | -36.5% | |
HNGR | HANGER INC | $155,000 | +14.8% | 20,836 | 0.0% | 0.06% | +10.5% | |
BAC | Bank Of America Corp | $133,000 | -1.5% | 10,009 | 0.0% | 0.05% | -5.3% | |
CDTX | New | Cidara Therapeutics | $122,000 | – | 11,850 | +100.0% | 0.05% | – |
Aptose Biosciences New | $29,000 | -19.4% | 12,000 | 0.0% | 0.01% | -20.0% | ||
APRI | Buy | Apricus Biosciences Inc | $26,000 | -18.8% | 64,356 | +15.5% | 0.01% | -15.4% |
BIOC | Biocept Inc | $25,000 | -49.0% | 37,736 | 0.0% | 0.01% | -52.4% | |
New | Arena Pharmaceuticals | $21,000 | – | 12,000 | +100.0% | 0.01% | – | |
RGLS | Exit | Regulus Therapeutics Inc | $0 | – | -28,617 | -100.0% | -0.08% | – |
IWB | Exit | Ishares Tr Russell | $0 | – | -2,157 | -100.0% | -0.10% | – |
DBEF | Exit | Dbx Trackers Msci Etf | $0 | – | -10,918 | -100.0% | -0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VANGUARD INTL EQUITY INDEX F | 42 | Q3 2023 | 25.5% |
SELECT SECTOR SPDR TR | 42 | Q3 2023 | 5.8% |
SELECT SECTOR SPDR TR | 42 | Q3 2023 | 3.8% |
SELECT SECTOR SPDR TR | 42 | Q3 2023 | 3.4% |
SELECT SECTOR SPDR TR | 42 | Q3 2023 | 3.4% |
SELECT SECTOR SPDR TR | 42 | Q3 2023 | 2.7% |
Vanguard Mid Cap | 42 | Q3 2023 | 2.7% |
SELECT SECTOR SPDR TR | 42 | Q3 2023 | 2.7% |
SELECT SECTOR SPDR TR | 42 | Q3 2023 | 1.8% |
Ishares Tr Dj US Finl | 42 | Q3 2023 | 1.0% |
View Callan Capital, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-03 |
13F-HR | 2024-02-02 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-04 |
13F-HR/A | 2023-06-13 |
13F-HR/A | 2023-06-13 |
13F-HR | 2023-05-09 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
View Callan Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.